Home - Products - Angiogenesis - PKC - Miltefosine

Miltefosine

CAS No. 58066-85-6

Miltefosine( HePC )

Catalog No. M15130 CAS No. 58066-85-6

Miltefosine is used for the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trials for this use in several other countries.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
50MG	28	In Stock
100MG	37	In Stock
200MG	Get Quote	In Stock
500MG	83	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Miltefosine
Note

Research use only, not for human use.
Brief Description

Miltefosine is used for the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trials for this use in several other countries.
Description

Miltefosine is used for the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trials for this use in several other countries. Several medical agents have some efficacy against visceral or cutaneous leishmaniasis, however a 2005 survey concluded that miltefosine is the only effective oral treatment for both forms of leishmaniasis.
In Vitro

——
In Vivo

——
Synonyms

HePC
Pathway

Angiogenesis
Target

PKC
Recptor

PKC
Research Area

Infection
Indication

——

Chemical Information

CAS Number

58066-85-6
Formula Weight

407.58
Molecular Formula

C21H46NO4P
Purity

>98% (HPLC)
Solubility

Ethanol: 82 mg/mL (201.19 mM); Water: 82 mg/mL (201.19 mM)
SMILES

O=P(OCCCCCCCCCCCCCCCC)([O-])OCC[N+](C)(C)C
Chemical Name

hexadecyl (2-(trimethylammonio)ethyl) phosphate

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Uberall F, et al. Y Res, 1991, 51(3), 807-812.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

BJE6-106

BJE6-106 (B106)?is a potent, selective PKCδ inhibitor with IC50 of 50 nM, displays excellent selectivity over classical PKC isozymes.
CGP60474

A potent CDK1 inhibitor with IC50 of 17 nM; exhibits lower potency at CDK2 and moderate potency at CDK4.
[Ala107]-MBP (104-11...

Synthetic peptide analog of bovine myelin basic protein (MBP). Non-competitive inhibitor of PKC (IC50 = 46 - 145 mM).

Sign In Join Free